![]() |
Image 1: (POM) NorLevo 1.5mg Packaging. |
On the 15th of February 2011, after having rejected the manufacturer's first application for a POM to P switch only a year before, and much to everyone's surprise, the Irish Medicines Board (IMB) approved the morning after pill NorLevo for over the counter supply by a pharmacist.
The switch caught much of the profession off guard, causing a lot of confusion in the first few weeks following this announcement. At the same time the IMB also launched a legal challenge to Boots' Emergency Contraception Service which launched only a month earlier.
Boots have been providing prescription only contraception tablets Levonelle and NorLevo under their in-house developed patient group direction (PGD). This is a protocol, authorised by a doctor, through which a pharmacist may supply a prescription only medicine without the need for the customer to see the doctor first.